| Literature DB >> 35965831 |
Lu Peng1, Qiang Bao1, Xiaoli Hong1, Weichao Li1, Yukai Zheng1, Zijun Zou1, Wenhua Liao1, Canxia Huang1.
Abstract
Background: The incidence of deep venous thrombosis (DVT) is higher in surgical patients, but there have been few studies on the risk factors of DVT in intensive care unit (ICU) patients after oral cancer surgery, particularly in relation to the inflammatory and nutritional scores, and intervene with these risk factors early may decrease the occurrence of DVT.Entities:
Keywords: Neutrophil to lymphocyte ratio; deep venous thrombosis (DVT); intensive care unit (ICU); oral cancer
Year: 2022 PMID: 35965831 PMCID: PMC9372679 DOI: 10.21037/atm-22-2453
Source DB: PubMed Journal: Ann Transl Med ISSN: 2305-5839
Figure 1The workflow of patients in our study. DVT, deep venous thrombosis.
Clinical characteristics of the DVT and non-DVT groups
| Variables | Non-DVT group (n=85) | DVT group (n=43) | P value |
|---|---|---|---|
| Age (years) | 67.0 (59.8–79.0) | 71.0 (62.5–79.25) | 0.339 |
| Gender (male/female) | 57/28 | 25/18 | 0.321 |
| BMI (kg/m2) | 21.44±3.9 | 22.53±4.0 | 0.146 |
| Chemoradiotherapy history (no/yes) | 75/10 | 36/7 | 0.477 |
| Operation history (no/yes) | 77/8 | 38/5 | 0.695 |
| Diabetes history (no/yes) | 69/16 | 36/7 | 0.723 |
| Hypertension history (no/yes) | 36/31 | 16/17 | 0.621 |
| CHD history (no/yes) | 71/14 | 37/6 | 0.711 |
| Surgical variables | |||
| Operative time (min) | 355.0 (275.00–442.50) | 360 (250.00–470.00) | 0.998 |
| Blood loss (mL) | 300.0 (200.0–300.0) | 300.0 (200.0–400.0) | 0.771 |
| Flap type (pedicle flap/free flap) | 8/73 | 5/31 | 0.750 |
| Preoperative laboratory data | |||
| Hemoglobin (g/dL) | 121.0±23.3 | 114.1±23.5 | 0.117 |
| Activated partial thromboplastin time (s) | 26.95 (25.40–29.30) | 27.15 (25.02–30.00) | 0.682 |
| Albumin (g/dL) | 36.55 (34.10–40.92) | 36.35 (33.30–39.30) | 0.201 |
| Creatinine (mg/dL) | 84.00 (66.75–97.50) | 80.50 (68.25–99.00) | 0.328 |
| D-dimer (μg/mL) | 0.66 (0.31–1.92) | 1.11 (0.56–2.25) | 0.093 |
| TC (mmol/L) | 4.75±1.22 | 5.05±1.27 | 0.218 |
| TG (mmol/L) | 1.07 (0.85–1.50) | 1.16 (0.94–1.46) | 0.491 |
| HDL-C (mmol/L) | 1.12±0.28 | 1.11±0.29 | 0.891 |
| LDL-C (mmol/L) | 3.02±0.90 | 3.26±0.91 | 0.176 |
| GLU (mmol/L) | 4.90 (4.58–5.90) | 5.65 (4.90–7.23) | 0.017* |
| Postoperative laboratory data | |||
| Albumin (g/dL) | 30.28±5.5 | 28.87±5.6 | 0.181 |
| D-dimer (μg/mL) | 3.64 (1.92–6.16) | 5.81 (2.73–10.61) | 0.009* |
| Anticoagulation therapy (no/yes) | 43/42 | 20/23 | 0.663 |
| APACHE II score | 17.9±5.4 | 19.3±6.9 | 0.197 |
| Charlson comorbidity index | 1 (0–2) | 1 (0–2) | 0.924 |
| CRS | 12.0 (11.0–14.0) | 12.5 (10.25–14.0) | 0.360 |
| MVT (days) | 2.0 (1–3.75) | 4.0 (2.0–6.0) | 0.003* |
| LOS (days) | 15.0 (12.0–19.0) | 20.0 (18.0–25.0) | 0.004* |
Quantitative variables with a normal distribution were expressed as mean ± SD and with abnormal distribution were expressed as median (interquartile range). *, P<0.05. DVT, deep venous thrombosis; BMI, body mass index; CHD, coronary heart disease; TC, total cholesterol; TG, triglyceride; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; GLU, glucose; APACHE II, Acute Physiology and Chronic Health Evaluation II; CRS, Caprini Risk Score; MVT, mechanical ventilation time; LOS, length of stay.
Comparison of the inflammatory and nutritional scores between non-DVT group and DVT group
| Variables | Non-DVT group (n=85) | DVT group (n=43) | P value |
|---|---|---|---|
| NLR | 2.54 (1.66–4.29) | 4.60 (2.50–9.52) | <0.001* |
| PLR | 164.10 (117.26–223.33) | 173.85 (139.46–308.94) | 0.067 |
| PNI | 36.25 (33.45–40.90) | 36.89 (33.02–39.67) | 0.828 |
Data were expressed as median (interquartile range). *, P<0.05. DVT, deep venous thrombosis; NLR, neutrophil to lymphocyte ratio; PLR, plate to lymphocyte ratio; PNI, prognostic nutritional index.
Prediction of DVT, AUROC, and cut-off points
| Variables | AUROC (95% CI) | Sensitivity | Specificity | Cut-off point |
|---|---|---|---|---|
| MVT (days) | 0.64 (0.53–0.74) | 0.615 | 0.631 | 2.5 |
| Preoperative D-dimer (μg/mL) | 0.59 (0.49–0.70) | 0.513 | 0.667 | 1.03 |
| Postoperative D-dimer (μg/mL) | 0.65 (0.54–0.74) | 0.538 | 0.741 | 5.57 |
| GLU (mmol/L) | 0.64 (0.53–0.74) | 0.641 | 0.612 | 5.15 |
DVT, deep venous thrombosis; AUROC, area under the ROC curve; MVT, mechanical ventilation time; GLU, glucose; CI, confidence interval.
Univariate and multivariate logistic regression analyses for DVT of patients with oral cancer after surgery in ICU
| Variables | Univariate analysis | Multivariate analysis | |||
|---|---|---|---|---|---|
| OR (95% CI) | P value | OR (95% CI) | P value | ||
| BMI (kg/m2) | 1.07 (0.97–1.18) | 0.154 | 1.090 (0.963–1.232) | 0.172 | |
| CRS | 1.10 (0.93–1.30) | 0.285 | 1.063 (0.868–1.301) | 0.555 | |
| MVT (days) | 0.005* | ||||
| ≤2.5 | 1 | 1 | |||
| >2.5 | 2.981 (1.328–6.430) | 1.854 (0.695–4.950) | 0.218 | ||
| Preoperative D-dimer (μg/mL) | 0.053 | ||||
| ≤1.03 | 1 | 1 | |||
| >1.03 | 2.10 (0.99–4.44) | 0.859 (0.311–2.378) | 0.770 | ||
| Postoperative D-dimer (μg/mL) | 0.005* | ||||
| ≤5.57 | 1 | 1 | |||
| >5.57 | 3.00 (1.39–6.48) | 4.766 (1.765–112.874) | 0.002* | ||
| GLU (mmol/L) | 0.011* | ||||
| ≤5.15 | 1 | 1 | |||
| >5.15 | 2.66 (1.25–5.67) | 3.061 (1.147–8.163) | 0.025* | ||
| NLR | 1.259 (1.090–1.454) | 0.002* | 1.342 (1.130–1.594) | 0.001* | |
*, P<0.05. DVT, deep venous thrombosis; ICU, intensive care unit; BMI, body mass index; CRS, Caprini Risk Score; MVT, mechanical ventilation time; GLU, glucose; NLR, neutrophil to lymphocyte ratio; OR, odds ratio; CI, confidence interval.
Figure 2ROC curves for NLR in predicting DVT. AUC, area under the curve; ROC, receiver operating characteristic; NLR, neutrophil to lymphocyte ratio; DVT, deep venous thrombosis.
Figure 3The correlation of NLR with LOS (A) and MVT (B). NLR, neutrophil to lymphocyte ratio; LOS, length of stay; MVT, mechanical ventilation time.